Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7299
    +0.0001 (+0.02%)
     
  • CRUDE OIL

    82.68
    -0.13 (-0.16%)
     
  • Bitcoin CAD

    88,157.19
    -3,422.15 (-3.74%)
     
  • CMC Crypto 200

    1,394.41
    -29.69 (-2.08%)
     
  • GOLD FUTURES

    2,329.70
    -8.70 (-0.37%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,479.75
    -184.75 (-1.05%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,906.36
    -553.72 (-1.44%)
     
  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Analysts Remain Bullish on Intercept Pharmaceuticals

Analysts Remain Bullish on Intercept Pharmaceuticals

In October, of the 17 analysts covering Intercept Pharmaceuticals (ICPT), eight have given the stock “buy” or higher ratings, and eight have given it “hold” ratings. One analyst has given Intercept a “sell.”